The upward trend in ZTS stock price is consistent with bullish MACD signals, and volatility remains relatively contained compared to biotech peers, adding stability for swing traders. Based on these projections and cash flow discounting, Zoetis’ intrinsic value comes out to $179.08 per share. This is roughly 18.2% higher than its current trading price, which suggests the stock is undervalued according to this analysis. It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. ZTS stock price surged after the company reported higher-than-expected sales in livestock segment, driven by recovering global meat production.
